Abstract
The mechanism underlying the sleep-inducing effect of oleamide, an endogenous fatty acid amide, was studied in rats. Animals implanted with cerebrocortical and dorsal neck muscle electrodes were monitored continuously by electroencephalograph (EEG) and electromyograph (EMG) for 4 h after i.p. or s.c. injection of drugs. Oleamide induced a dose-dependent increase in slow-wave sleep (SWS), a decrease in wakefulness (W) and sleep latency, but had no effect on rapid-eye-movement sleep (REMS). The oleamide-induced increase in SWS was prevented by 5-HT reuptake inhibitors such as fluoxetine or fenfluramine and by agonists at 5-HT1A receptors such as buspirone or 8-hydroxy-2-(di-N-propylamino) tetralin (8-OH-DPAT). Moreover, the selective 5-HT1A receptor antagonist WAY100635 markedly antagonized the suppression of the oleamide-induced increase in SWS by 8-OH-DPAT. These data provide the first behavioural evidence that the serotonergic system may be involved in the sleep-inducing action of oleamide in rats.
Similar content being viewed by others
References
Basile AS, Hanus L, Mendelson WB (1999) Characterization of the hypnotic properties of oleamide. Neuroreport 10:947–951
Boger DL, Henriksen SJ, Cravatt BF (1998a) Oleamide: an endogenous sleep-inducing lipid and prototypical member of a new class of biological signaling molecules. Curr Pharm Des 4: 303–314
Boger DL, Patterson JE, Jin Q (1998b) Structural requirements for 5-HT2A and 5-HT1A serotonin receptor potentiation by the biological active lipid oleamide. Proc Natl Acad Sci USA 95:4102–4107
Cape EG, Jones BE (1998) Differential modulation of high frequency gamma electroencephalogram activity and sleep-wake state by noradrenaline and serotonin microinjections into the region of cholinergic basalis neurons. J Neurosci 18:2653–2666
Cheer JF, Cadogan AK, Marsden CA, Fone KC, Kendall DA(1999) Modification of 5-HT2 receptor mediated behaviour in the rat by oleamide and the role of cannabinoid receptor. Neurophamarcology 38:533–541
Coyne L, Lees G, Nicholson RA, Zheng J, Neufield KD (2002) The sleep hormone oleamide modulates inhibitory ionotropic receptors in mammalian CNS in vitro. Br J Pharmacol 135:1977–1987
Cravatt BF, Prospero-Garcia O, Siuzdak G, Gilula NB, Henriksen SJ, Boger DL, Lerner RA (1995) Chemical characterization of a family of brain lipids that induce sleep. Science 268:1506–1509
Cravatt BF, Giang DK, Mayfield SP, Boger DL, Lerner RA, Gilula NB (1996) Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides. Nature 384:83–87
De Montigny C, Blier P (1984) Effects of antidepressant treatments on 5-HT neurotransmission: electrophysiological and clinical studies. Adv Biochem Psychopharmacol 39:223–239
Fedorova I, Hashimoto A, Fecik RA, Hedrick MP, Hanus LO, Boger DL, Rice KC, Basile AS (2001) Behavioral evidence for the interaction of oleamide with multiple neurotransmitter systems. J Pharmacol Exp Ther 299:332–342
Fornal C, Radulovacki M (1983a) Sleep suppressant action of fenfluramine in rats: Relation to postsynaptic serotonergic stimulation. J Pharmacol Exp Ther 225:667–674
Fornal C, Radulovacki M (1983b) Sleep suppressant action of fenfluramine in rats: evidence against the involvement of presynaptic serotonergic mechanism. J Pharmacol Exp Ther 225:675–681
Gao B, Duncan WC Jr, Wehr TA (1992) Fluoxetine decreases brain temperature and REM sleep in Syrian hamsters. Psychopharmacology 106:321–329
Hedlund PB, Carson MJ, Sutcliffe JG, Thomas EAl (1999) Allosteric regulation by oleamide of the binding properties of 5-hydroxytryptamine7 receptors. Biochem Pharmacol 58: 1807–1813
Huidobro-Toro JP, Harris RA (1996) Brain lipids that induce sleep are novel modulators of 5-HT receptors. Proc Natl Acad Sci USA 93:8078–8082
Huitron-Resendiz S, Gombart L, Cravatt BF, Henriksen SJ (2001) Effect of oleamide on sleep and its relationship to blood pressure, body temperature, and locomotor activity in rats. Exp Neurol 172:235–243
Hyttel J (1994) Pharmacological characterization of the selective serotonin reuptake inhibitors (SSRI’s). Int Clin Psychopharmacol 9:19–26
Laposky AD, Homanics GE, Basile A, Mendelson WB (2001) Deletion of the GABA(A) receptor beta 3 subunit eliminates the hypnotic actions of oleamide in mice. Neuroreport 12:4143–4147
Lees G, Edwards MD, Hassoni AA, Ganellin CR, Galanakis D (1998) Modulation of GABAA receptors and inhibitory synaptic currents by the endogenous CNS sleep regulator cis-9,10-octadecenoamide (cOA). Br J Pharmacol 124:873–882
Lerman JA, Kaitin KI, Dement WC, Peroutka SJ (1986) The effects of buspirone on sleep in the rat. Neurosci Lett 72:64–68
Mechoulam R, Fride E, Hanus L, Sheskin T, Bisogno T, Di Marzo V, Bayewitch M, Vogel Z (1997) Anandamide may mediate sleep induction. Nature 389:25–26
Mendelson WB, Basile AS (1999) The hypnotic actions of oleamide are blocked by a cannabinoid receptor antagonist. Neuroreport 10:3237–3239
Mendelson WB, Basile AS (2000) Synergistic interaction of the hypnotic effects of oleamide and triazolam (abstract). Sleep 23 (Suppl. 2):A162
Mistlberger RE, Bergamnn BM, Waldenar W, Rechtschaffen A (1983) Recovery sleep following sleep deprivation in intact and suprachiastmatic nuclei-lesioned rats. Sleep 6:217–233
Monti JM, Jantos H (1992) Dose-dependent effects of the 5-HT1A receptor agonist 8-OH-DPAT on sleep and wakefulness in the rat. J Sleep Res 1:169–175
Monti JM, Jantos H (1994) Stereoselective antagonism by the pindolol enantiomers of 8-OH-DPAT-induced changes of sleep and wakefulness Neuropharmacology 33:705–708
Monti JM, Jantos H, Silveira R, Reyes-Parada M, Scorza C (1995) Sleep and waking in 5,7-DHT-lesioned or (−)-pindolol-pretreated rats after administration of buspirone, ipsapirone, or gepirone. Pharmacol Biochem Behav 52:305–312
Nicholson AN, Pascoe PA (1988) Studies on the modulation of the sleep-wakefulness continuum in man by fluoxetine, a 5-HT uptake inhibitor. Neuropharmacology 27:597–602
Obal F Jr, Tobler I, Borbley AA (1983) Effect of ambient temperature on 24 h sleep-wake cycle in normal and caspsaician treated rats. Physiol Behav 30:425–430
Pastel RH, Fernstrom JD (1987) Short-term effects of fluoxetine and trifluoromethylphenylpiperazine on EEG in the rat. Brain Res 436:92–102
Portas CM, Bjorvatn B, Ursin R (2000) Serotonin and the sleep/wake cycle: special emphasis on microdialysis studies. Prog Neurobiol 60:13–35
Sakai K, Crochet S (2001) Differentiation of presumed serotonergic dorsal raphe neurons in relation to behavior and wake-sleep states. Neuroscience 104:1141–1155
Sorensen E, Gronli J, Bjorvatn B, Ursin R (2001) The selective 5-HT1A receptor antagonist p-MPPI antagonizes sleep-waking and behavioral effects of 8-OH-DPAT in rats. Behav Brain Res 121:181–187
Thomas EA, Carson MJ, Neal MJ, Sutcliffe JG (1997) Unique allosteric regulation of 5-HT receptor-mediated signal transduction by oleamide. Proc Natl Acad Sci USA 94: 14115–14119
Thomas EA, Carson MJ, Sutcliffe JG (1998) Oleamide-induced modulation of 5-hydroxytryptamine receptor-mediated signaling. Ann NY Acad Sci 861:183–189
Thomas TC, Kumar VM (2000) Effect of ambient temperature on sleep-wakefulness in normal and medial preoptic are lesioned rats. Sleep Res Online 3:141–145
Verdon B, Zheng J, Nicholson RA, Ganelli CR, Lees G (2000) Stereoselective modulatory actions of oleamide on GABAA receptors and voltage-gated Na+ channels in vitro: a putative endogenous ligand for depressant drug site in CNS. Br J Pharmacol 129:283–290
Yang JY, Wu CF, Song HR (1999) Studies on the sedative and hypnotic effects of oleamide in mice. Arzneim-Forsch/Drug Res 49:663–667
Acknowledgements
This project is partially supported by Liaoning Nature Science Foundation.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Yang, JY., Wu, CF., Wang, F. et al. The serotonergic system may be involved in the sleep-inducing action of oleamide in rats. Naunyn-Schmiedeberg's Arch Pharmacol 368, 457–462 (2003). https://doi.org/10.1007/s00210-003-0843-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00210-003-0843-z